This aligns with observations from our previous study involving cohorts of CLL patients revealing the prognostic value of an accumulation in circulation of the UGCG products GluCer and elevated UGCG mRNA leukemic expression, both as adverse prognostic markers [5]. Here, UGCG is linked to B-cell chronic lymphocytic leukemia.